Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: Mirror Image who wrote (1515)	10/1/2015 2:49:26 PM
From: eico20	Read Replies (1) \| Respond to of 2026

just got this email from Matt Beck - Sandoz is not releasing product in Germany until after they complete an internal quality review process. They continue to sell in Belgium and Sweden as do all of Apricus’ other partners. This a Sandoz process issue. Regards, Matt

To: Mirror Image who wrote (1515)	10/1/2015 7:25:47 PM
From: phoenix_rising	Read Replies (1) \| Respond to of 2026

That is correct MI, it does make the US deal look good. Latin America has about 6-700 million people, but the target audience with money will be so much smaller than that. That certain Ihub poster is a boorish dick, but I don't actually think he is clever enough to be flipping from short to long.